Sign inJoin waitlistJoin the waitlist

Katharine McGinigle

Surgical Director of ERAS · University of North Carolina Hospitals

Credentials: · · · ·

History

ERAS · University of North Carolina Hospitals
Present
University of North Carolina Hospitals
Present
University of North Carolina Hospitals
Present

Surgery
University of North Carolina Hospitals
2016–2023
Vascular Surgery
Duke University Hospital
2013–2015
University of North Carolina School of Public Health
University of North Carolina School of Medicine
2009–2013
Tufts University, Medford, MA
2000–2004

Research

The Reporting on ERAS Compliance, Outcomes, and Elements Research (RECOvER) Checklist: A Joint Statement by the ERAS® and ERAS® USA Societies
World Journal of Surgery · 2019 · 187 citations
The use of active surveillance cultures in adult intensive care units to reduce methicillin-resistant Staphylococcus aureus-related morbidity, mortality, and costs: a systematic…
Systematic review or meta-analysis · Clinical Infectious Diseases · 2008 · First of 3 authors · Corresponding · 89 citations
Perioperative care in open aortic vascular surgery: A consensus statement by the Enhanced Recovery After Surgery (ERAS) Society and Society for Vascular Surgery
Review · Journal of Vascular Surgery · 2022 · First of 17 authors · Corresponding · 64 citations

William Marston
24 papers
Mark Farber
19 papers
Luigi Pascarella
17 papers
Alik Farber
12 papers
MM
Matthew Menard
12 papers
Jason Crowner
10 papers
Michael Conte
10 papers
Federico Parodi
9 papers · 9 as a resident
Samantha Minc
9 papers
Olamide Alabi
8 papers
Jacob Wood
7 papers
JC
Jayer Chung
7 papers

Grants

Tailored Treatment Strategies for Patients with Chronic Limb Threatening Ischemia
National Heart, Lung, and Blood Institute · R01
Contact PI · $1.4M · Univ of North Carolina Chapel Hill
2025–2029
Machine Learning-Based Staging System to Predict Chronic Limb-Threatening Ischemia Disease Progression and Survival: A Secondary Analysis of the BEST-CLI Trial Data
National Heart, Lung, and Blood Institute · R21
Contact PI · $233.3K · Univ of North Carolina Chapel Hill
2023–2025

Clinical trials

Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
Site PI · Recruiting · Phase 3
Population Health Research Institute
2021–2029